Parallax Volatility Advisers, L.P. Edwards Lifesciences Corp Call Options Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $18.1 Million - $28.4 Million	302,800 Added 43257.14%	303,500 $20 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $5.86 Million - $6.55 Million	-69,500 Reduced 99.0%	700 $64,000
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $1.28 Million - $1.69 Million	17,700 Added 33.71%	70,200 $6.71 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $3.53 Million - $4.45 Million	-57,200 Reduced 52.14%	52,500 $4 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $3.35 Million - $4.51 Million	48,300 Added 78.66%	109,700 $7.6 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $8 Million - $9.27 Million	-98,300 Reduced 61.55%	61,400 $5.79 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $9.77 Million - $11.1 Million	131,600 Added 468.33%	159,700 $13.2 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $1.25 Million - $1.6 Million	-18,300 Reduced 39.44%	28,100 $2.1 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $3.75 Million - $4.88 Million	45,500 Added 5055.56%	46,400 $3.83 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $2.54 Million - $3.77 Million	-29,400 Reduced 97.03%	900 $86,000
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $285,488 - $359,352	2,800 Added 10.18%	30,300 $3.57 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $1.15 Million - $1.41 Million	-10,800 Reduced 28.2%	27,500 $3.56 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $2.87 Million - $3.42 Million	-27,900 Reduced 42.15%	38,300 $4.34 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $10.5 Million - $13.1 Million	-125,500 Reduced 65.47%	66,200 $6.86 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $5.47 Million - $6.96 Million	76,300 Added 66.12%	191,700 $17.5 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $4.61 Million - $6 Million	68,600 Added 146.58%	115,400 $9.21 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.2 Million - $1.61 Million	20,900 Added 80.69%	46,800 $3.23 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $1.31 Million - $2.03 Million	25,000 Added 2777.78%	25,900 $4.89 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $64,530 - $73,881	900 New	900 $210,000
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $7.8 Million - $9.02 Million	-140,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $6.7 Million - $8.97 Million	140,000 New	140,000 $26.8 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account